J2060Lorazepam injection
Published CMS Medicare Part B payment-limit context for J2060, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$2.302
per 2 MG · Medicare Part B
Up 38.7%from $1.66 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$2.4402$1.1768
2024-Q4: $1.456; 2025-Q1: $1.351; 2025-Q2: $1.565; 2025-Q3: $1.315; 2025-Q4: $1.377; 2026-Q1: $1.406; 2026-Q2: $1.66; 2026-Q3: $2.302
Ingredient appears in FDA shortage dataFDA’s latest completed shortage data includes an affected record matching the Lorazepam ingredient family (FDA data as of August 20, 2026).
Lorazepam
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.